Monday, December 6, 2021

Latest Chinese Drug Coverage Comes With Steep Price Cuts, Caveats - SCRIP Intelligence

Asia Deal Watch: Astellas Looks To Next-Gen AAV Vectors Despite Gene Therapy Clinical Setbacks. Astellas inks agreement with Dyno Therapeutics for ...
https://www.google.com/url?rct=j&sa=t&url=https://scrip.pharmaintelligence.informa.com/SC145531/Latest-Chinese-Drug-Coverage-Comes-With-Steep-Price-Cuts-Caveats&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHf_Kj7mc2H3y3H-2xK1URQvgt67w

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...